Sheila Gujrathi, MD, physician-scientist and biotech founder with 25 years across Genentech, BMS and multiple startups. She recounts moving from medicine into biotech, building and exiting companies, and navigating today's deal landscape. She explores the inspiration for The Mirror Effect, leadership frameworks for women, overcoming fear and imposter feelings, and building supportive networks like the CEO Sisterhood.
39:59
forum Ask episode
web_stories AI Snips
view_agenda Chapters
menu_book Books
auto_awesome Transcript
info_circle Episode notes
question_answer ANECDOTE
From Academic Medicine To Genentech Journey
Sheila left academic medicine after training to pursue broader impact in biotech.
She moved from Brigham/Stanford/UCSF training to McKinsey then Genentech in 2002, valuing great people and culture in each step.
volunteer_activism ADVICE
Choose Roles That Match Your Mission
Figure out your mission and values, then choose roles that align with them rather than following external expectations.
Sheila encourages an open mind about industry careers and says today's collaboration between academia and industry makes switching more acceptable.
insights INSIGHT
Large Company Experience Scales To Startups
Working first in large companies teaches systems, people, and drug development rigor you can use at startups.
Sheila spent early years at Genentech and BMS, then transitioned 15 years ago to CMO, founder, and board roles leveraging that experience.
Get the Snipd Podcast app to discover more snips from this episode
Synopsis:
This episode is proudly sponsored by Quartzy.
Physician-scientist, biotech founder, and leadership advocate Sheila Gujrathi, MD joins Rahul Chaturvedi on the Biotech 2050 Podcast for a powerful conversation at the intersection of biotech innovation, leadership, and personal transformation.
Sheila shares the unconventional journey that led her from academic medicine to the forefront of biotechnology—spanning roles at Genentech and Bristol Myers Squibb, founding companies, serving on boards, and recently helping guide Ventus Therapeutics through its acquisition by Lilly. Along the way, she reflects on the lessons she learned building drugs, scaling companies, and navigating the evolving biotech deal environment.
The discussion then turns deeply personal as Sheila explores the ideas behind her book “The Mirror Effect,” revealing how self-awareness, supportive networks, and authentic leadership can transform careers—especially for women and underrepresented leaders in science. From overcoming imposter syndrome to building the “CEO Sisterhood” network of women biotech leaders, Sheila shares hard-earned insights on navigating power, culture, and identity in high-stakes industries.
For founders, investors, and leaders alike, this episode blends biotech strategy with deeply human lessons on resilience, purpose, and the power of believing in yourself.
Biography:
SHEILA GUJRATHI, MD, is a biotech entrepreneur, executive, and champion for under- represented leaders. Over the past 25 years, she’s had the privilege of developing life-changing medicines for patients with serious diseases while building and running private and public biotech companies—including some exciting exits. Today she’s a founder, chairwoman, board director, strategic advisor, and consultant to start-up companies and investment funds.
Dr. Gujrathi was the co-founder and former CEO of Gossamer Bio and former Chief Medical Officer of Receptos. Her journey started at Northwestern University, where she earned both her M.D. and biomedical engineering degree, and took her from the halls of Harvard, UCSF, and Stanford to the corporate offices of Fortune 500 companies like McKinsey, Genentech, and Bristol-Myers Squibb.
Dr. Gujrathi has earned multiple leadership awards, including AIMBE Fellow, BLOC100 Luminary, Healthcare Technology Report Top 25 Women Leaders in Biotechnology, Corporate Directors Forum Director of the Year, and Fiercest Women in Life Sciences. But what really lights her up is creating the inclusive environments she wished she’d had throughout her career. That’s why she co-founded the Biotech CEO Sisterhood, a group of trailblazing female CEOs—because we’re all better when we support each other.
Biotech 2050 Podcast 
